» Articles » PMID: 20021200

Molecular Cloning and Enzymatic Characterization of Sheep CYP2J

Overview
Journal Xenobiotica
Publisher Informa Healthcare
Specialties Biochemistry
Toxicology
Date 2009 Dec 22
PMID 20021200
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cytochrome P450 (CYP) 2Js have been studied in various mammals, but not in sheep, as an animal model used to test veterinary drug metabolism. Sheep CYP2J was cloned from liver messenger RNA (mRNA) by RACE. The cDNA, after modification at its N- and C-terminals, was expressed in Escherichia coli and the sheep CYP2J protein, purified by chromatography, was 80% homologous to human and monkey CYP2J2. Reverse transcriptase-polymerase chain reaction (RT-PCR) experiments showed that CYP2J mRNA was expressed in liver, cortex, respiratory and olfactory mucosa, heart, bronchi, lung, spleen, small intestine and kidney. The purified enzyme was catalytically active towards aminopyrine, all-trans-retinoic acid, and particularly arachidonic acid forming 20-HETE, 19-HETE, and 18-HETE (about 86% of the total) and 14,15-, 11,12-, 8,9-, and 5,6-EETs (cis-epoxyeicosatrienoic acids; about 14% of total), with a regioselectivity similar to that shown by the mammalian CYP2J2s.

Citing Articles

Exhaled breath condensate profiles of U.S. Navy divers following prolonged hyperbaric oxygen (HBO) and nitrogen-oxygen (Nitrox) chamber exposures.

Fothergill D, Borras E, McCartney M, Schelegle E, Davis C J Breath Res. 2023; 17(3).

PMID: 37207635 PMC: 11057948. DOI: 10.1088/1752-7163/acd715.


Expression and Characterization of Truncated Recombinant Human Cytochrome P450 2J2.

Park H, Lim Y, Han S, Kim D Toxicol Res. 2014; 30(1):33-8.

PMID: 24795797 PMC: 4007041. DOI: 10.5487/TR.2014.30.1.033.


Carbon-carbon bond cleavage in activation of the prodrug nabumetone.

Varfaj F, Zulkifli S, Park H, Challinor V, De Voss J, de Montellano P Drug Metab Dispos. 2014; 42(5):828-38.

PMID: 24584631 PMC: 3989788. DOI: 10.1124/dmd.114.056903.


Functional studies of N-terminally modified CYP2J2 epoxygenase in model lipid bilayers.

McDougle D, Palaria A, Magnetta E, Meling D, Das A Protein Sci. 2013; 22(7):964-79.

PMID: 23661295 PMC: 3719090. DOI: 10.1002/pro.2280.


Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism.

Michaud V, Frappier M, Dumas M, Turgeon J PLoS One. 2010; 5(12):e15666.

PMID: 21179487 PMC: 3001885. DOI: 10.1371/journal.pone.0015666.

References
1.
Coceani F, Kelsey L, Seidlitz E, Korzekwa K . Inhibition of the contraction of the ductus arteriosus to oxygen by 1-aminobenzotriazole, a mechanism-based inactivator of cytochrome P450. Br J Pharmacol. 1996; 117(7):1586-92. PMC: 1909445. DOI: 10.1111/j.1476-5381.1996.tb15325.x. View

2.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

3.
Ko I, Park S, Song B, Patten C, Tan Y, Hah Y . Monoclonal antibodies to ethanol-induced rat liver cytochrome P-450 that metabolizes aniline and nitrosamines. Cancer Res. 1987; 47(12):3101-9. View

4.
Zhang Q, Raner G, Ding X, Dunbar D, Coon M, Kaminsky L . Characterization of the cytochrome P450 CYP2J4: expression in rat small intestine and role in retinoic acid biotransformation from retinal. Arch Biochem Biophys. 1998; 353(2):257-64. DOI: 10.1006/abbi.1998.0654. View

5.
Capdevila J, Karara A, Waxman D, Martin M, Falck J, Guenguerich F . Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J Biol Chem. 1990; 265(19):10865-71. View